GL Control®
Advanced Blood Sugar Balance
& Glucose Support Formula

Berberine is the most clinically important ingredient in GL Control's formula and one of the most remarkable naturally-occurring compounds in metabolic medicine. A growing body of peer-reviewed research — including multiple randomized controlled trials — has demonstrated that berberine can lower fasting blood glucose and HbA1c (the gold-standard marker of long-term blood sugar control) with a magnitude of effect comparable to the prescription diabetes drug metformin in some studies. Its primary mechanism involves activation of AMPK (AMP-activated protein kinase), often called the "metabolic master switch" — triggering enhanced glucose uptake in muscle cells, improved insulin receptor sensitivity, and reduced hepatic glucose production. Berberine also favorably modifies the gut microbiome in ways that support metabolic health. At 500mg per serving, GL Control delivers the clinically relevant dose used in most positive clinical trials.

Ceylon cinnamon — "true cinnamon" — has emerged as one of the most studied botanical compounds for blood sugar support. Its active compounds (procyanidins and cinnamaldehyde) appear to mimic insulin activity and enhance insulin receptor sensitivity by activating insulin-signaling proteins in cells. Multiple clinical studies have demonstrated measurable reductions in fasting blood glucose, post-meal glucose peaks, and insulin resistance markers. Critically, GL Control uses Ceylon cinnamon rather than the cheaper, more common Cassia cinnamon — an important distinction because Cassia contains high levels of coumarin, which can be hepatotoxic at supplemental doses, while Ceylon cinnamon is essentially coumarin-free and safe for long-term use.

Chromium is an essential trace mineral with a well-documented role in insulin activity — it is a cofactor in the insulin receptor signaling pathway. The picolinate chelated form offers the best absorption profile of any supplemental chromium source. Clinical research has demonstrated chromium supplementation's ability to reduce insulin resistance markers, lower HbA1c in individuals with impaired glucose tolerance, and reduce carbohydrate cravings by stabilizing post-meal glucose fluctuations. Chromium deficiency — more common than generally recognized, particularly in those consuming refined carbohydrates — is directly associated with impaired glucose tolerance. At 200 mcg, GL Control provides the evidence-supported dose for meaningful glucose management support.

Bitter melon has been used in Ayurvedic and Traditional Chinese Medicine for blood sugar management for centuries, and modern research is increasingly validating this traditional use. Its active compounds — charantin, vicine, and polypeptide-P — have demonstrated insulin-like and glucose-lowering effects in multiple clinical studies. The mechanisms include inhibiting glucose absorption in the intestines, stimulating glucose uptake in peripheral tissues, and supporting pancreatic beta-cell function. The 10:1 extract concentration used in GL Control provides the potency equivalent of 2,000mg of whole bitter melon — a meaningful therapeutic dose.

Gymnema Sylvestre — known in Sanskrit as "sugar destroyer" — is a remarkable botanical with a dual mechanism of action for blood sugar management. Its active gymnemic acids structurally resemble glucose and can temporarily block sugar absorption in the intestines by occupying the receptors responsible for glucose uptake. Additionally, Gymnema appears to support pancreatic beta-cell regeneration and enhance insulin secretion in those with impaired pancreatic function. Multiple clinical studies have shown meaningful reductions in fasting blood glucose and HbA1c with Gymnema supplementation. Standardization to 25% gymnemic acids ensures consistent therapeutic potency.

Alpha Lipoic Acid is one of the most powerful antioxidants involved in glucose metabolism. ALA activates GLUT4 transporters — the proteins responsible for moving glucose from the bloodstream into muscle cells — thereby improving cellular glucose uptake without requiring additional insulin. It is also the only antioxidant that is both fat and water soluble, allowing it to neutralize oxidative stress in both aqueous and lipid cellular environments. Oxidative stress is a key mediator of insulin resistance and diabetes-related complications. ALA has been particularly studied for its protective role in diabetic peripheral neuropathy — a common and serious complication of long-term blood sugar dysregulation.

Banaba leaf extract, standardized to corosolic acid, has demonstrated meaningful post-meal blood glucose-lowering effects in multiple clinical trials, with some studies showing reductions in 2-hour post-meal blood sugar of up to 30% compared to placebo. Corosolic acid facilitates cellular glucose uptake through GLUT4 transporter activation — a similar mechanism to ALA, providing complementary and reinforcing action. Banaba is also rich in lagerstroemia speciosa and ellagitannins with antioxidant properties. This ingredient is particularly relevant for addressing post-meal glucose spikes, which are an independent cardiovascular risk factor distinct from fasting blood glucose.